Bangladesh vs Sub-Saharan Africa (IDA & IBRD countries): Immunization, Hib3
Immunization, Hib3 over time
- Bangladesh
- Sub-Saharan Africa (IDA & IBRD countries)
How they compare
Bangladesh currently reports 97.0% against 74.0% in Sub-Saharan Africa (IDA & IBRD countries), a difference of 23.0%.
That makes Bangladesh's figure about 1.3 times Sub-Saharan Africa (IDA & IBRD countries)'s.
Across all 16 years both countries report, Bangladesh has been ahead every year.
Bangladesh ranks 29th and Sub-Saharan Africa (IDA & IBRD countries) ranks 32nd of 191 countries.
Bangladesh has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bangladesh | Sub-Saharan Africa (IDA & IBRD countries) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.0% | 57.9% | 39.1% | Bangladesh |
| 2010s | 95.8% | 68.4% | 27.4% | Bangladesh |
| 2020s | 97.2% | 73.4% | 23.8% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Bangladesh or Sub-Saharan Africa (IDA & IBRD countries)?
- Bangladesh, at 97.0% against 74.0% in Sub-Saharan Africa (IDA & IBRD countries) as of 2024.
- What is the difference in immunization, hib3 between Bangladesh and Sub-Saharan Africa (IDA & IBRD countries)?
- 23.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Sub-Saharan Africa (IDA & IBRD countries)?
- 16 years are reported by both, from 2009 to 2024.
- How do Bangladesh and Sub-Saharan Africa (IDA & IBRD countries) rank globally for immunization, hib3?
- Bangladesh ranks 29th and Sub-Saharan Africa (IDA & IBRD countries) ranks 32nd of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.